Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+67.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.7x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $169.59M | +20.7% |
| 2024 | $140.47M | +131.4% |
| 2023 | $60.70M | +66.7% |
| 2022 | $36.41M | +13.8% |
| 2021 | $32.00M | - |